GE HealthCare unveils Pristina Recon DL for mammography – deep learning image reconstruction technology delivering clearer image quality

GE HealthCare announced that it has received FDA Premarket Authorization for Pristina Recon DL, an advanced 3D mammography image reconstruction technology. Powered by deep learning, Pristina Recon DL sets a new standard in image definition and sharpness. Powered by artificial intelligence (AI), Pristina Recon DL delivers sharper images with fewer artifacts, enhanced details, and greater consistency – helping clinicians make more confident diagnoses.a

Pristina Recon DL leverages two deep learning models working in sequence to enable separation of meaningful signal from noise. The first model reconstructs high fidelity 3D volumes with greater purity – minimizing artifacts and perceived noise The second model is trained to enhance the visualization of clinically relevant information in the DL synthesized 2D view.

A recent study showed that Pristina Recon DL overall image quality was preferred by breast radiologists in 99.1% of the image reviews compared to previous DBT reconstruction. It also offers superior performance in the detection of microcalcification clusters and masses, demonstrated in a trial with modeled clinical data.

“With Pristina Via with Recon DL, we’re setting a new benchmark in breast imaging — delivering sharper, clearer, and more consistent images that empower radiologists with more confidence,” said Pooja Pathak, Vice President and General Manager, Mammography at GE HealthCare. “As an upgradable feature on the Pristina Via platform, we are excited to now offer customers uncompromised image quality combined with fast, accurate workflows.”

“Pristina Recon DL was born out of a deep commitment to our customers – listening closely to their feedback and working hand-in-hand with radiologists to enhance image quality and clarity,” said Dr. Jyoti Gupta, President and CEO, Women’s Health and X-ray at GE HealthCare. “By applying advanced deep learning technologies, we’re shaping the future of breast imaging – one defined by uncompromised image quality, faster workflows, and greater confidence in early cancer detection.”

“We value GE HealthCare listening and innovating with us in mammography. Upgrading to Pristina Via has refined our exam workflow, making it more efficient and patient-focused,” said Dr. Gary Dee, President, Midstate Radiology Associates, LLC. “Now, with the introduction of Pristina Recon DL, we’re excited to see a new level of image quality that reinforces our confidence in delivering breast cancer care.”

“Our collaboration with GE HealthCare has been instrumental in advancing breast imaging capabilities, and the new 3D image quality represents a meaningful upgrade that will benefit radiologists and patients alike,” said Dr. Howard Berger, President and Chief Executive Officer of RadNet. “This pioneering AI technology will help elevate breast care by delivering the clarity and consistency radiologists need to enable more confident diagnoses.”